Ginkgo Bioworks Holdings DNA
NYSE DNA
$6.80 -0.14 (-2.09%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Gross Margin Growth (1y) (2021 - 2026)

Analysis

Ginkgo Bioworks Holdings (DNA) Gross Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn -8.00
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn -133.00
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn 169.00
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn -538.00
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn 173.00
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn 522.00
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn 963.00
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn -326.00
10 VivoSim Labs 1.47 Mn 1.47 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 522.00
Mar 31, 2026 -521.00
Dec 31, 2025 -58.00
Sep 30, 2025 -984.00
Jun 30, 2025 726.00
Mar 31, 2025 1,355.00
Dec 31, 2024 -1,758.00
Sep 30, 2024 127.00
Jun 30, 2024 145.00
Mar 31, 2024 347.00
Dec 31, 2023 1,010.00
Sep 30, 2023 2,464.00
Jun 30, 2023 2,004.00
Mar 31, 2023 1,820.00
Dec 31, 2022 4,532.00
Sep 30, 2022 -1,282.00
Jun 30, 2022 -746.00
Mar 31, 2022 -1,471.00
Dec 31, 2021 -3,280.00
Sep 30, 2021 -1,102.00